Literature DB >> 19190508

Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report.

Naren P Rao1, Pradeep Palaniyappan, Jyothsna Chandur, Ganesan Venkatasubramanian, Bangalore N Gangadhar.   

Abstract

Cognitive deficits are commonly associated with maintenance electroconvulsive therapy (ECT). Treatment of these cognitive deficits is important but difficult. Cholinergic pathways are involved in these side effects, and donepezil, a cholinesterase inhibitor, may be useful for improvement of cognition. In this case report, we describe for the first time successful use of donepezil in treating cognitive deficits associated with maintenance ECT. The role of cholinesterase inhibitors in the treatment of cognitive deficits caused by ECT needs further studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190508     DOI: 10.1097/YCT.0b013e3181926ada

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  5 in total

1.  Therapeutic and prophylactic role of cognitive enhancers in electroconvulsive therapy-induced cognitive deficits.

Authors:  Jyoti Prakash; Suprakash Chaudhury; Kaushik Chatterjee; A Kotwal; Kalpana Srivastava; Amitav Saha
Journal:  Ind Psychiatry J       Date:  2020-08-14

2.  Efficacy of memoral herbal on prevention of electroconvulsive therapy-induced memory impairment in mood disorder patients (isfahan - iran 2011).

Authors:  Seyed Ghafur Mousavi; Ghasemi Mohsen; Maracy M Reza; Ebrahimi Amrollah; Barekatain Majid; Noori Fariba
Journal:  Int J Prev Med       Date:  2012-07

3.  Clinical Effectiveness of Maintenance Electroconvulsive Therapy in Patients with Schizophrenia: A Retrospective Cohort Study.

Authors:  Moshe Isserles; Jesse Remington; Tyler S Kaster; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  J ECT       Date:  2020-03       Impact factor: 3.692

4.  Pathogenetic and therapeutic perspectives on neurocognitive models in psychiatry: A synthesis of behavioral, brain imaging, and biological studies.

Authors:  Naren P Rao
Journal:  Indian J Psychiatry       Date:  2012-07       Impact factor: 1.759

5.  Medication management during electroconvulsant therapy.

Authors:  Monica Zolezzi
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-19       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.